Second BIC Webinar successfully delivered! More than 70 participants attended the second BIC webinar on “How to Commercialise your Biomarker Discovery” on August 27, 2020.
This webinar went into more detail about the Biomarker Commercialization project with the focus on European IVD Regulation with a speaker from the Finnish Medicines Agency FIMEA.
The webinar dived into the regulatory requirements for biomarker development and commercialization, an important know-how for any research group, SME or TTO working with biomarker development.
The IVD regulation is also covered in detail in the Biomarker Commercialization (BIC) toolset, designed to support, step-by-step, both academic researchers and SMEs when developing a biomarker-based invention to a commercial product. The BIC toolset includes a Biomarker Commercialization Guide, which covers technical, clinical, commercial and regulatory aspects, a Best Practices Handbook based on experiences from TTOs in the field, and a review tool for TTOs and a Guide for Regulatory Process. The toolset has been created in the BIC project funded by Interreg Baltic Sea Region Programme, and it will be available for free in summer 2020.
- Introduction to European IVD regulation – requirements for biomarker product development and commercialization (Nelli Karhu, Finnish Medicines Agency FIMEA)
- Moderator: Teppo Laaksonen, Network Manager, Turku Science Park Ltd
We are happy to announce that the Best Practices and Pitfalls in Commercializing IVD-Applicable Biomarkers Handbook is now available from biomarker.nu webpage.